BARRECA, Marilia
BARRECA, Marilia
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
[1,2]OXAZOLE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST MULTIPLE MALIGNANT CELL TYPES
2021-05-04
A critical analysis on ENaC inhibitors, unravelling molecular medicinal insights and promising research roadmap in the treatment of cystic fibrosis
2026-10-05 Lo Mascolo, F.; Lipani, A.; Giuffrida, S.; Barreca, M.; Bivacqua, R.; Spano, V.; Raimondi, M.V.; Montalbano, A.; Borrelli, A.; Venturini, A.; Guidone, D.; Genovese, M.; Galietta, L.J.V.; Barraja, P.
A Tetrahydro-isoquinoline derivative as a novel mGlu2/3 Ago/PAM with therapeutic potential in models of Parkinsonism
2026-01-01 Urone, G.; Scordino, M.; Frinchi, M.; Montalbano, A.; Barreca, M.; Barraja, P.; Raimondi, M.V.; Bivacqua, R.; Battaglia, G.; Malhaire, F.; Goudet, C.; Mudò, G.; Spanò, V.; Di Liberto, V.
Advances in developing noncovalent small molecules targeting Keap1
2023-12-01 Barreca, Marilia; Qin, Yuting; Cadot, Marie Elodie Hélène; Barraja, Paola; Bach, Anders
An overview on anti-tubulin agents for the treatment of lymphoma patients
2020-01-01 Barreca M.; Stathis A.; Barraja P.; Bertoni F.
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
2022-12-01 Barreca M.; Lang N.; Tarantelli C.; Spriano F.; Barraja P.; Bertoni F.
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis
2024-08-28 Scalia F.; Culletta G.; Barreca M.; Caruso Bavisotto C.; Bivacqua R.; D'Amico G.; Alberti G.; Spano' V.; Tutone M.; Almerico A.M.; Cappello F.; Montalbano A.; Barraja P.
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines
2024-10-04 Raimondi, M.V.; Rigogliuso, S.; Saiano, F.; Poma, P.; Labbozzetta, M.; Barreca, M.; Barbera, M.; Bivacqua, R.; Li Petri, G.; Buscemi, S.; Sardo, I.; Spano, V.; Palumbo Piccionello, A.; Montalbano, A.; Barraja, P.; Notarbartolo, M.
Current development of CFTR potentiators in the last decade
2020-01-01 Spano' V.; Venturini A.; Genovese M.; Barreca M.; Raimondi M.V.; Montalbano A.; Galietta L.J.V.; Barraja P.
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas
2022-12-05 Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Abel A.-C.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Steinmetz M.O.; Prota A.E.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P.
Editorial: Emerging heterocycles as bioactive compounds
2023-04-26 Li Petri, Giovanna; Holl, Ralph; Spano', Virginia; Barreca, Marilia; Sardo, Ignazio; Raimondi, Maria Valeria
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells
2020-10-01 Barreca M.; Spanò Virginia; Raimondi M.V.; Montalbano A.; Bai R.; Gaudio E.; Alcaro S.; Hamel E.; Bertoni Francesco; Barraja P.
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
2021-01-01 Spano' V.; Barreca M.; Cilibrasi V.; Genovese M.; Renda M.; Montalbano A.; Galietta L.J.V.; Barraja P.
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis
2023-05-05 Barreca, M.; Buttacavoli, M.; Di Cara, G.; D'Amico, C.; Peri, E.; Spano', V.; Li Petri, G.; Barraja, P.; Raimondi, M.V.; Cancemi, P.; Montalbano, A.
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction
2025-09-22 Lin, C.; Narayanan, D.; Barreca, M.; Poulsen, C.; Da Costa, L.S.; Chen, X.; Wichman, K.G.; Charley, C.A.; Lindsay, J.L.; Dezfouli, M.; Vlissari, D.; Mortensen, T.S.; Chan, C.B.; Wang, J.; Richardson, W.; Manning, C.E.; Chen, Z.; Zang, J.; Käck, H.; Gajhede, M.; Bullock, A.N.; Blake, D.J.; Olagnier, D.; Bach, A.
GPCR Inhibition in Treating Lymphoma
2022-02-15 Barreca M.; Spano' V.; Raimondi M.V.; Bivacqua R.; Giuffrida S.; Montalbano A.; Cavalli A.; Bertoni F.; Barraja P.
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches
2023-04-11 Bivacqua, R.; Romeo, I.; Barreca, M.; Barraja, P.; Alcaro, S.; Montalbano, A.
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis
2024-01-01 Barreca M.; Renda M.; Spano' V.; Montalbano A.; Raimondi M.V.; Giuffrida S.; Bivacqua R.; Bandiera T.; Galietta L.J.V.; Barraja P.
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas
2023-06-05 Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Gualtieri G.; Raimondi M.V.; Gaudio E.; Bortolozzi R.; Manfreda L.; Bai R.; Montalbano A.; Alcaro S.; Hamel E.; Bertoni F.; Viola G.; Barraja P.
In Silico-Guided Design, Synthesis and In Vitro Evaluation of Thiazolo-pyridines Targeting SARS-CoV-2 Nsp13
2026-01-01 Bivacqua, R.; Emmolo, R.; Gualtieri, G.; Di Martino, S.; Barreca, M.; Spano', V.; Raimondi, M.V.; Corona, A.; Ortuso, F.; Tramontano, E.; Romeo, I.; Montalbano, A.; Barraja, P.; Alcaro, S.
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 4-mag-2021 | [1,2]OXAZOLE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST MULTIPLE MALIGNANT CELL TYPES | BARRECA, Marilia | 04 - Tesi di dottorato::4.2 Tesi di dottorato | - | |
| 5-ott-2026 | A critical analysis on ENaC inhibitors, unravelling molecular medicinal insights and promising research roadmap in the treatment of cystic fibrosis | Lo Mascolo, FabianaLipani, AlessandraGiuffrida, StefanoBarreca, MariliaBivacqua, RobertaSpano, VirginiaRaimondi, Maria ValeriaMontalbano, AlessandraBarraja, Paola + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Lo Mascolo, F.; Lipani, A.; Giuffrida, S.; Barreca, M.; Bivacqua, R.; Spano, V.; Raimondi, M.V.; Montalbano, A.; Borrelli, A.; Venturini, A.; Guidone, D.; Genovese, M.; Galietta, L.J.V.; Barraja, P. | |
| 1-gen-2026 | A Tetrahydro-isoquinoline derivative as a novel mGlu2/3 Ago/PAM with therapeutic potential in models of Parkinsonism | Giulia UroneMiriana ScordinoMonica FrinchiAlessandra MontalbanoMarilia BarrecaPaola BarrajaMaria Valeria RaimondiRoberta BivacquaVirginia SpanòValentina Di Liberto + | 01 - Contributo in rivista::1.01 Articolo in rivista | Urone, G.; Scordino, M.; Frinchi, M.; Montalbano, A.; Barreca, M.; Barraja, P.; Raimondi, M.V.; Bivacqua, R.; Battaglia, G.; Malhaire, F.; Goudet, C.; Mudò, G.; Spanò, V.; Di Liberto, V. | |
| 1-dic-2023 | Advances in developing noncovalent small molecules targeting Keap1 | Barreca, MariliaBarraja, Paola + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Barreca, Marilia; Qin, Yuting; Cadot, Marie Elodie Hélène; Barraja, Paola; Bach, Anders | |
| 1-gen-2020 | An overview on anti-tubulin agents for the treatment of lymphoma patients | Barreca M.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Stathis A.; Barraja P.; Bertoni F. | |
| 1-dic-2022 | Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences | Barreca M.Barraja P. + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Barreca M.; Lang N.; Tarantelli C.; Spriano F.; Barraja P.; Bertoni F. | |
| 28-ago-2024 | Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis | Scalia F.Culletta G.Barreca M.Caruso Bavisotto C.Bivacqua R.D'Amico G.Alberti G.Spano' V.Tutone M.Almerico A. M.Cappello F.Montalbano A.Barraja P. | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Scalia F.; Culletta G.; Barreca M.; Caruso Bavisotto C.; Bivacqua R.; D'Amico G.; Alberti G.; Spano' V.; Tutone M.; Almerico A.M.; Cappello F.; Montalbano A.; Barraja P. | |
| 4-ott-2024 | Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines | Maria Valeria RaimondiSalvatrice RigogliusoFilippo SaianoPaola PomaManuela LabbozzettaMarilia BarrecaMarcella BarberaRoberta BivacquaGiovanna Li PetriSilvestre BuscemiIgnazio SardoVirginia SpanoAntonio Palumbo PiccionelloAlessandra MontalbanoPaola BarrajaMonica Notarbartolo | 01 - Contributo in rivista::1.01 Articolo in rivista | Raimondi, M.V.; Rigogliuso, S.; Saiano, F.; Poma, P.; Labbozzetta, M.; Barreca, M.; Barbera, M.; Bivacqua, R.; Li Petri, G.; Buscemi, S.; Sardo, I.; Spano, V.; Palumbo Piccionello, A.; Montalbano, A.; Barraja, P.; Notarbartolo, M. | |
| 1-gen-2020 | Current development of CFTR potentiators in the last decade | Spano' V.Barreca M.Raimondi M. V.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Spano' V.; Venturini A.; Genovese M.; Barreca M.; Raimondi M.V.; Montalbano A.; Galietta L.J.V.; Barraja P. | |
| 5-dic-2022 | Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas | Barreca M.Spano' V.Bivacqua R.Montalbano A.Raimondi M. V.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Abel A.-C.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Steinmetz M.O.; Prota A.E.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P. | |
| 26-apr-2023 | Editorial: Emerging heterocycles as bioactive compounds | Spano', VirginiaBarreca, MariliaSardo, IgnazioRaimondi, Maria Valeria + | 01 - Contributo in rivista::1.11 Nota o commento | Li Petri, Giovanna; Holl, Ralph; Spano', Virginia; Barreca, Marilia; Sardo, Ignazio; Raimondi, Maria Valeria | |
| 1-ott-2020 | Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells | Barreca M.Spanò VirginiaRaimondi M. V.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.05 Abstract in atti di convegno pubblicato in rivista | Barreca M.; Spanò Virginia; Raimondi M.V.; Montalbano A.; Bai R.; Gaudio E.; Alcaro S.; Hamel E.; Bertoni Francesco; Barraja P. | |
| 1-gen-2021 | Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein | Spano' V.Barreca M.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Spano' V.; Barreca M.; Cilibrasi V.; Genovese M.; Renda M.; Montalbano A.; Galietta L.J.V.; Barraja P. | |
| 5-mag-2023 | Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis | Barreca, MariliaButtacavoli, MiriamDi Cara, GianlucaD'Amico, CesarePeri, EmanuelaSpano', VirginiaBarraja, PaolaRaimondi, Maria ValeriaCancemi, PatriziaMontalbano, Alessandra + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca, M.; Buttacavoli, M.; Di Cara, G.; D'Amico, C.; Peri, E.; Spano', V.; Li Petri, G.; Barraja, P.; Raimondi, M.V.; Cancemi, P.; Montalbano, A. | |
| 22-set-2025 | Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction | Barreca, Marilia + | 01 - Contributo in rivista::1.01 Articolo in rivista | Lin, C.; Narayanan, D.; Barreca, M.; Poulsen, C.; Da Costa, L.S.; Chen, X.; Wichman, K.G.; Charley, C.A.; Lindsay, J.L.; Dezfouli, M.; Vlissari, D.; Mortensen, T.S.; Chan, C.B.; Wang, J.; Richardson, W.; Manning, C.E.; Chen, Z.; Zang, J.; Käck, H.; Gajhede, M.; Bullock, A.N.; Blake, D.J.; Olagnier, D.; Bach, A. | |
| 15-feb-2022 | GPCR Inhibition in Treating Lymphoma | Barreca M.Spano' V.Raimondi M. V.Bivacqua R.Giuffrida S.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Spano' V.; Raimondi M.V.; Bivacqua R.; Giuffrida S.; Montalbano A.; Cavalli A.; Bertoni F.; Barraja P. | |
| 11-apr-2023 | HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches | Bivacqua R.Barreca M.Barraja P.Montalbano A. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bivacqua, R.; Romeo, I.; Barreca, M.; Barraja, P.; Alcaro, S.; Montalbano, A. | |
| 1-gen-2024 | Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis | Barreca M.Spano' V.Montalbano A.Raimondi M. V.Giuffrida S.Bivacqua R.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Renda M.; Spano' V.; Montalbano A.; Raimondi M.V.; Giuffrida S.; Bivacqua R.; Bandiera T.; Galietta L.J.V.; Barraja P. | |
| 5-giu-2023 | Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas | Barreca M.Spano' V.Bivacqua R.Raimondi M. V.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Gualtieri G.; Raimondi M.V.; Gaudio E.; Bortolozzi R.; Manfreda L.; Bai R.; Montalbano A.; Alcaro S.; Hamel E.; Bertoni F.; Viola G.; Barraja P. | |
| 1-gen-2026 | In Silico-Guided Design, Synthesis and In Vitro Evaluation of Thiazolo-pyridines Targeting SARS-CoV-2 Nsp13 | Bivacqua, RobertaDi Martino, SimonaBarreca, MariliaSpano', VirginiaRaimondi, Maria ValeriaMontalbano, AlessandraBarraja, Paola + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bivacqua, R.; Emmolo, R.; Gualtieri, G.; Di Martino, S.; Barreca, M.; Spano', V.; Raimondi, M.V.; Corona, A.; Ortuso, F.; Tramontano, E.; Romeo, I.; Montalbano, A.; Barraja, P.; Alcaro, S. |